| Financial Year |
March 31 2023 |
| Monetary Funds |
70,793,279.18 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
2,741,424.00 |
| Accounts Receivable |
19,827,551.69 |
| Advances to Suppliers |
6,171,177.79 |
| Other Receivables |
3,957,076.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
155,303,007.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,926,066.80 |
| Total Current Assets |
509,822,085.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,838,767.16 |
| Investment Properties |
244,670,364.00 |
| Fixed Assetes |
143,618,736.40 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,024,961.93 |
| R&D expenses |
827,087.55 |
| Goodwill |
11,485,077.64 |
| Long-Term Deferred and Prepaid Expenses |
3,467,538.07 |
| Deferred Income Tax Assets |
15,023,555.94 |
| Other Non-Current Assets |
2,487,700.00 |
| Sub-Total of Non-Current Assets |
495,799,721.09 |
| Total Assets |
1,005,621,806.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
95,604,603.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,612,805.30 |
| Taxes Payable |
2,986,990.40 |
| Interest Payable |
-- |
| Dividend Payable |
121,146.50 |
| Other payables |
63,217,847.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
511,416.09 |
| Other Current Liabilities |
5,011,276.40 |
| Sub-Total of Current Liabilities |
283,989,540.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
500,000.00 |
| Deferred Income Tax Liabilities |
40,001,192.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,971,041.72 |
| Total Liabilities |
328,960,581.90 |
| Paid-In Capital(Or Share Stock) |
377,788,586.00 |
| Capital Surplus |
2,237,671,053.68 |
| Surplus Reserve |
5,030,274.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,951,262,489.04 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
676,661,224.56 |
| Owner's Equity（Stockholder's Equity） |
676,661,224.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,005,621,806.46 |
